Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 2
2004 2
2006 1
2008 1
2009 1
2011 1
2014 2
2015 1
2016 1
2017 1
2018 5
2019 2
2020 5
2021 2
2022 2
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

28 results

Results by year

Filters applied: . Clear all
Page 1
SKAP2 acts downstream of CD11b/CD18 and regulates neutrophil effector function.
Bouti P, Klein BJAM, Verkuijlen PJH, Schornagel K, van Alphen FPJ, Taris KH, van den Biggelaar M, Hoogendijk AJ, van Bruggen R, Kuijpers TW, Matlung HL. Bouti P, et al. Among authors: verkuijlen pjh. Front Immunol. 2024 Feb 29;15:1344761. doi: 10.3389/fimmu.2024.1344761. eCollection 2024. Front Immunol. 2024. PMID: 38487529 Free PMC article.
Cancer cells resist antibody-mediated destruction by neutrophils through activation of the exocyst complex.
van Rees DJ, Bouti P, Klein B, Verkuijlen PJH, van Houdt M, Schornagel K, Tool ATJ, Venet D, Sotiriou C, El-Abed S, Izquierdo M, Guillaume S, Saura C, Di Cosimo S, Huober J, Roylance R, Kim SB, Kuijpers TW, van Bruggen R, van den Berg TK, Matlung HL. van Rees DJ, et al. Among authors: verkuijlen pjh. J Immunother Cancer. 2022 Jun;10(6):e004820. doi: 10.1136/jitc-2022-004820. J Immunother Cancer. 2022. PMID: 35728876 Free PMC article.
Sodium stibogluconate and CD47-SIRPα blockade overcome resistance of anti-CD20-opsonized B cells to neutrophil killing.
van Rees DJ, Brinkhaus M, Klein B, Verkuijlen P, Tool ATJ, Schornagel K, Treffers LW, van Houdt M, Kater AP, Vidarsson G, Gennery AR, Kuijpers TW, van Bruggen R, Matlung HL, van den Berg TK. van Rees DJ, et al. Among authors: verkuijlen p. Blood Adv. 2022 Apr 12;6(7):2156-2166. doi: 10.1182/bloodadvances.2021005367. Blood Adv. 2022. PMID: 34942000 Free PMC article.
Membrane Dynamics and Organization of the Phagocyte NADPH Oxidase in PLB-985 Cells.
Joly J, Hudik E, Lecart S, Roos D, Verkuijlen P, Wrona D, Siler U, Reichenbach J, Nüsse O, Dupré-Crochet S. Joly J, et al. Among authors: verkuijlen p. Front Cell Dev Biol. 2020 Nov 12;8:608600. doi: 10.3389/fcell.2020.608600. eCollection 2020. Front Cell Dev Biol. 2020. PMID: 33365312 Free PMC article.
Kindlin3-Dependent CD11b/CD18-Integrin Activation Is Required for Potentiation of Neutrophil Cytotoxicity by CD47-SIRPα Checkpoint Disruption.
Bouti P, Zhao XW, Verkuijlen PJJH, Tool ATJ, van Houdt M, Köker N, Köker MY, Keskin O, Akbayram S, van Bruggen R, Kuijpers TW, Matlung HL, van den Berg TK. Bouti P, et al. Among authors: verkuijlen pjjh. Cancer Immunol Res. 2021 Feb;9(2):147-155. doi: 10.1158/2326-6066.CIR-20-0491. Epub 2020 Dec 22. Cancer Immunol Res. 2021. PMID: 33355195
MKL1 deficiency results in a severe neutrophil motility defect due to impaired actin polymerization.
Sprenkeler EGG, Henriet SSV, Tool ATJ, Kreft IC, van der Bijl I, Aarts CEM, van Houdt M, Verkuijlen PJJH, van Aerde K, Jaspers G, van Heijst A, Koole W, Gardeitchik T, Geissler J, de Boer M, Tol S, Bruggeman CW, van Alphen FPJ, Verhagen HJMP, van den Akker E, Janssen H, van Bruggen R, van den Berg TK, Liem KD, Kuijpers TW. Sprenkeler EGG, et al. Among authors: verkuijlen pjjh. Blood. 2020 Jun 11;135(24):2171-2181. doi: 10.1182/blood.2019002633. Blood. 2020. PMID: 32128589 Free article.
IgA-Mediated Killing of Tumor Cells by Neutrophils Is Enhanced by CD47-SIRPα Checkpoint Inhibition.
Treffers LW, Ten Broeke T, Rösner T, Jansen JHM, van Houdt M, Kahle S, Schornagel K, Verkuijlen PJJH, Prins JM, Franke K, Kuijpers TW, van den Berg TK, Valerius T, Leusen JHW, Matlung HL. Treffers LW, et al. Among authors: verkuijlen pjjh. Cancer Immunol Res. 2020 Jan;8(1):120-130. doi: 10.1158/2326-6066.CIR-19-0144. Epub 2019 Nov 5. Cancer Immunol Res. 2020. PMID: 31690649
28 results